Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Xynomic Pharma In-Licenses Global Rights to HDAC Inhibitor for Cancer
  Fudan-Zhangjiang Bio-Pharma Invests $2 Million in Adgero of the US
  Qilu Pharma Launches Biosimilar to AstraZeneca's Iressa in China
  Anxin Doctor, a Mobile Health App, Announces $28 Million Funding
  BioSense Inks $68 Million Deal for Neovacs’ Autoimmune Disease Vaccine in China
  Hong Kong's Ally Bridge Invests in Two European Biopharmas
  Lee's Pharm to Market Solasia's Oral Mucositis Treatment in China
  Hutchison MediTech Begins Phase II Study of Its PSC Drug Savolitinib in China
  Eisai to Market Orion’s Two Parkinson’s Disease Drugs in China
  Denovo Biopharma Plans to Initiate a Global Phase III Trial of DLBCL Drug
 
Login